UniProt ID | BCL9L_HUMAN | |
---|---|---|
UniProt AC | Q86UU0 | |
Protein Name | B-cell CLL/lymphoma 9-like protein | |
Gene Name | BCL9L | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1499 | |
Subcellular Localization | Nucleus . | |
Protein Description | Transcriptional regulator that acts as an activator. Promotes beta-catenin transcriptional activity. Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1 (By similarity).. | |
Protein Sequence | MRILANKTRLPHPRRREAPGSPPLSPRGHCPPAPAKPMHPENKLTNHGKTGNGGAQSQHQNVNQGPTCNVGSKGVGAGNHGAKANQISPSNSSLKNPQAGVPPFSSLKGKVKRDRSVSVDSGEQREAGTPSLDSEAKEVAPRSKRRCVLERKQPYSGDEWCSGPDSEEDDKPIGATHNCNVADPAMAAPQLGPGQTTQLPLSESSVPGAPHGPPPGLRPDAPGGGGGGGGVPGKPPSQFVYVFTTHLANTAAEAVLQGRADSILAYHQQNVPRAKLDQAPKVPPTPEPLPLSTPSAGTPQSQPPPLPPPPPPAPGSAPPALPPEGPPEDSSQDLAPNSVGAASTGGGTGGTHPNTPTATTANNPLPPGGDPSSAPGPALLGEAAAPGNGQRSLVGSEGLSKEQLEHRERSLQTLRDIERLLLRSGETEPFLKGPPGGAGEGGPPAQAPPPPQQPPTAPPSGLKKYEEPLQSMISQTQSLGGPPLEHEVPGHPPGGDMGQQMNMMIQRLGQDSLTPEQVAWRKLQEEYYEEKRRKEEQIGLHGSRPLQDMMGMGGMMVRGPPPPYHSKPGDQWPPGMGAQLRGPMDVQDPMQLRGGPPFPGPRFPGNQIQRVPGFGGMQSMPMEVPMNAMQRPVRPGMGWTEDLPPMGGPSNFAQNTMPYPGGQGEAERFMTPRVREELLRHQLLEKRSMGMQRPLGMAGSGMGQSMEMERMMQAHRQMDPAMFPGQMAGGEGLAGTPMGMEFGGGRGLLSPPMGQSGLREVDPPMGPGNLNMNMNVNMNMNMNLNVQMTPQQQMLMSQKMRGPGDLMGPQGLSPEEMARVRAQNSSGVMGGPQKMLMPSQFPNQGQQGFSGGQGPYQAMSQDMGNTQDMFSPDQSSMPMSNVGTTRLSHMPLPPASNPPGTVHSAPNRGLGRRPSDLTISINQMGSPGMGHLKSPTLSQVHSPLVTSPSANLKSPQTPSQMVPLPSANPPGPLKSPQVLGSSLSVRSPTGSPSRLKSPSMAVPSPGWVASPKTAMPSPGVSQNKQPPLNMNSSTTLSNMEQGTLPPSGPRSSSSAPPANPPSGLMNPSLPFTSSPDPTPSQNPLSLMMTQMSKYAMPSSTPLYHNAIKTIATSDDELLPDRPLLPPPPPPQGSGPGISNSQPSQMHLNSAAAQSPMGMNLPGQQPLSHEPPPAMLPSPTPLGSNIPLHPNAQGTGGPPQNSMMMAPGGPDSLNAPCGPVPSSSQMMPFPPRLQQPHGAMAPTGGGGGGPGLQQHYPSGMALPPEDLPNQPPGPMPPQQHLMGKAMAGRMGDAYPPGVLPGVASVLNDPELSEVIRPTPTGIPEFDLSRIIPSEKPSSTLQYFPKSENQPPKAQPPNLHLMNLQNMMAEQTPSRPPNLPGQQGVQRGLNMSMCHPGQMSLLGRTGVPPQQGMVPHGLHQGVMSPPQGLMTQQNFMLMKQRGVGGEVYSQPPHMLSPQGSLMGPPPQQNLMVSHPLRQRSVSLDSQMGYLPAPGGMANLPF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Acetylation | -MRILANKTRLPHPR -CCCCCCCCCCCCCC | 29.43 | 25953088 | |
21 | Phosphorylation | RRREAPGSPPLSPRG CCCCCCCCCCCCCCC | 23.45 | 29255136 | |
25 | Phosphorylation | APGSPPLSPRGHCPP CCCCCCCCCCCCCCC | 20.51 | 29255136 | |
36 | Acetylation | HCPPAPAKPMHPENK CCCCCCCCCCCCCCC | 41.64 | 19608861 | |
43 | Acetylation | KPMHPENKLTNHGKT CCCCCCCCCCCCCCC | 55.84 | 21466224 | |
49 | Acetylation | NKLTNHGKTGNGGAQ CCCCCCCCCCCCCCC | 45.79 | 23954790 | |
73 | Acetylation | PTCNVGSKGVGAGNH CCCCCCCCCCCCCCC | 52.25 | 23954790 | |
83 | Acetylation | GAGNHGAKANQISPS CCCCCCCCCCCCCCC | 53.08 | 26051181 | |
88 | Phosphorylation | GAKANQISPSNSSLK CCCCCCCCCCCCCCC | 16.71 | 22167270 | |
90 | Phosphorylation | KANQISPSNSSLKNP CCCCCCCCCCCCCCC | 42.42 | 30266825 | |
92 | Phosphorylation | NQISPSNSSLKNPQA CCCCCCCCCCCCCCC | 41.19 | 30266825 | |
93 | Phosphorylation | QISPSNSSLKNPQAG CCCCCCCCCCCCCCC | 47.84 | 30266825 | |
105 | Phosphorylation | QAGVPPFSSLKGKVK CCCCCCHHHCCCCCC | 40.30 | 23927012 | |
106 | Phosphorylation | AGVPPFSSLKGKVKR CCCCCHHHCCCCCCC | 34.18 | 25159151 | |
108 | Acetylation | VPPFSSLKGKVKRDR CCCHHHCCCCCCCCC | 59.64 | 19608861 | |
110 | Acetylation | PFSSLKGKVKRDRSV CHHHCCCCCCCCCCE | 42.89 | 23954790 | |
116 | Phosphorylation | GKVKRDRSVSVDSGE CCCCCCCCEECCCCC | 24.04 | 29255136 | |
118 | Phosphorylation | VKRDRSVSVDSGEQR CCCCCCEECCCCCCC | 22.81 | 29255136 | |
121 | Phosphorylation | DRSVSVDSGEQREAG CCCEECCCCCCCCCC | 41.91 | 25159151 | |
129 | Phosphorylation | GEQREAGTPSLDSEA CCCCCCCCCCCCHHH | 19.42 | 29255136 | |
131 | Phosphorylation | QREAGTPSLDSEAKE CCCCCCCCCCHHHHH | 44.65 | 21815630 | |
134 | Phosphorylation | AGTPSLDSEAKEVAP CCCCCCCHHHHHHCC | 44.76 | 23403867 | |
137 | Acetylation | PSLDSEAKEVAPRSK CCCCHHHHHHCCHHH | 48.98 | 19608861 | |
275 | Ubiquitination | QQNVPRAKLDQAPKV HHCCCHHHHCCCCCC | 54.60 | - | |
401 | Ubiquitination | VGSEGLSKEQLEHRE CCCCCCCHHHHHHHH | 55.30 | - | |
410 | Phosphorylation | QLEHRERSLQTLRDI HHHHHHHHHHHHHHH | 21.78 | 20068231 | |
424 | Phosphorylation | IERLLLRSGETEPFL HHHHHHHCCCCCCCC | 40.73 | 25159151 | |
432 | Acetylation | GETEPFLKGPPGGAG CCCCCCCCCCCCCCC | 70.52 | 26051181 | |
460 | Phosphorylation | QPPTAPPSGLKKYEE CCCCCCCCHHHHCHH | 56.55 | 28555341 | |
465 | Phosphorylation | PPSGLKKYEEPLQSM CCCHHHHCHHHHHHH | 24.76 | 28985074 | |
476 | Phosphorylation | LQSMISQTQSLGGPP HHHHHHHHHHCCCCC | 17.21 | 28985074 | |
512 | Phosphorylation | IQRLGQDSLTPEQVA HHHHCCCCCCHHHHH | 26.67 | 22199227 | |
514 | Phosphorylation | RLGQDSLTPEQVAWR HHCCCCCCHHHHHHH | 28.82 | 21815630 | |
522 | Sumoylation | PEQVAWRKLQEEYYE HHHHHHHHHHHHHHH | 43.77 | - | |
522 | Sumoylation | PEQVAWRKLQEEYYE HHHHHHHHHHHHHHH | 43.77 | - | |
527 | Phosphorylation | WRKLQEEYYEEKRRK HHHHHHHHHHHHHHH | 18.54 | - | |
531 | Ubiquitination | QEEYYEEKRRKEEQI HHHHHHHHHHHHHHH | 45.63 | - | |
534 | Acetylation | YYEEKRRKEEQIGLH HHHHHHHHHHHHCCC | 70.41 | 12656583 | |
564 | Phosphorylation | VRGPPPPYHSKPGDQ ECCCCCCCCCCCCCC | 25.21 | 28634298 | |
566 | Phosphorylation | GPPPPYHSKPGDQWP CCCCCCCCCCCCCCC | 34.40 | 20068231 | |
593 | Methylation | VQDPMQLRGGPPFPG CCCCCHHCCCCCCCC | 31.00 | - | |
602 | Dimethylation | GPPFPGPRFPGNQIQ CCCCCCCCCCCCCCE | 57.20 | - | |
602 | Methylation | GPPFPGPRFPGNQIQ CCCCCCCCCCCCCCE | 57.20 | - | |
610 | Methylation | FPGNQIQRVPGFGGM CCCCCCEECCCCCCC | 37.92 | - | |
668 | Methylation | GGQGEAERFMTPRVR CCCCHHHHHCCHHHH | 33.41 | - | |
675 | Methylation | RFMTPRVREELLRHQ HHCCHHHHHHHHHHH | 32.71 | - | |
680 | Asymmetric dimethylarginine | RVREELLRHQLLEKR HHHHHHHHHHHHHHH | 28.29 | - | |
680 | Methylation | RVREELLRHQLLEKR HHHHHHHHHHHHHHH | 28.29 | - | |
705 | Phosphorylation | AGSGMGQSMEMERMM CCCCHHHHHHHHHHH | 15.81 | 28348404 | |
750 | Phosphorylation | GGGRGLLSPPMGQSG CCCCCCCCCCCCCCC | 31.81 | 29255136 | |
756 | Phosphorylation | LSPPMGQSGLREVDP CCCCCCCCCCCCCCC | 33.78 | 30266825 | |
813 | Phosphorylation | LMGPQGLSPEEMARV CCCCCCCCHHHHHHH | 36.77 | 28355574 | |
821 | Methylation | PEEMARVRAQNSSGV HHHHHHHHHHCCCCC | 25.54 | - | |
888 | O-linked_Glycosylation | NVGTTRLSHMPLPPA CCCCCCCCCCCCCCC | 17.91 | 30059200 | |
896 | O-linked_Glycosylation | HMPLPPASNPPGTVH CCCCCCCCCCCCCCC | 56.49 | 30059200 | |
896 | Phosphorylation | HMPLPPASNPPGTVH CCCCCCCCCCCCCCC | 56.49 | 22210691 | |
915 | Phosphorylation | RGLGRRPSDLTISIN CCCCCCCHHCEEEEE | 43.36 | 27273156 | |
918 | Phosphorylation | GRRPSDLTISINQMG CCCCHHCEEEEECCC | 20.05 | 23927012 | |
920 | Phosphorylation | RPSDLTISINQMGSP CCHHCEEEEECCCCC | 15.39 | 23927012 | |
926 | Phosphorylation | ISINQMGSPGMGHLK EEEECCCCCCCCCCC | 16.97 | 25159151 | |
934 | Phosphorylation | PGMGHLKSPTLSQVH CCCCCCCCCCHHHCC | 29.49 | 30266825 | |
936 | Phosphorylation | MGHLKSPTLSQVHSP CCCCCCCCHHHCCCC | 46.24 | 30266825 | |
938 | Phosphorylation | HLKSPTLSQVHSPLV CCCCCCHHHCCCCCC | 32.41 | 30266825 | |
942 | Phosphorylation | PTLSQVHSPLVTSPS CCHHHCCCCCCCCCC | 22.52 | 19664994 | |
946 | O-linked_Glycosylation | QVHSPLVTSPSANLK HCCCCCCCCCCCCCC | 42.47 | 30059200 | |
946 | Phosphorylation | QVHSPLVTSPSANLK HCCCCCCCCCCCCCC | 42.47 | 23401153 | |
947 | O-linked_Glycosylation | VHSPLVTSPSANLKS CCCCCCCCCCCCCCC | 14.91 | 30059200 | |
947 | Phosphorylation | VHSPLVTSPSANLKS CCCCCCCCCCCCCCC | 14.91 | 19664994 | |
949 | O-linked_Glycosylation | SPLVTSPSANLKSPQ CCCCCCCCCCCCCCC | 29.56 | 30059200 | |
949 | Phosphorylation | SPLVTSPSANLKSPQ CCCCCCCCCCCCCCC | 29.56 | 30266825 | |
954 | Phosphorylation | SPSANLKSPQTPSQM CCCCCCCCCCCHHHC | 25.96 | 28355574 | |
957 | Phosphorylation | ANLKSPQTPSQMVPL CCCCCCCCHHHCCCC | 28.43 | 28355574 | |
959 | Phosphorylation | LKSPQTPSQMVPLPS CCCCCCHHHCCCCCC | 34.00 | 25159151 | |
966 | Phosphorylation | SQMVPLPSANPPGPL HHCCCCCCCCCCCCC | 48.65 | 27251275 | |
975 | Phosphorylation | NPPGPLKSPQVLGSS CCCCCCCCCCCCCCC | 28.40 | 19664994 | |
981 | Phosphorylation | KSPQVLGSSLSVRSP CCCCCCCCCCEEECC | 24.76 | 23401153 | |
982 | Phosphorylation | SPQVLGSSLSVRSPT CCCCCCCCCEEECCC | 23.90 | 30278072 | |
984 | Phosphorylation | QVLGSSLSVRSPTGS CCCCCCCEEECCCCC | 19.89 | 30278072 | |
987 | Phosphorylation | GSSLSVRSPTGSPSR CCCCEEECCCCCHHH | 25.34 | 23401153 | |
989 | Phosphorylation | SLSVRSPTGSPSRLK CCEEECCCCCHHHCC | 52.09 | 23401153 | |
991 | Phosphorylation | SVRSPTGSPSRLKSP EEECCCCCHHHCCCC | 23.37 | 28355574 | |
993 | Phosphorylation | RSPTGSPSRLKSPSM ECCCCCHHHCCCCCC | 52.52 | 23927012 | |
997 | Phosphorylation | GSPSRLKSPSMAVPS CCHHHCCCCCCCCCC | 27.14 | 25159151 | |
999 | Phosphorylation | PSRLKSPSMAVPSPG HHHCCCCCCCCCCCC | 26.85 | 28355574 | |
1004 | Phosphorylation | SPSMAVPSPGWVASP CCCCCCCCCCCCCCC | 29.46 | 28355574 | |
1010 | O-linked_Glycosylation | PSPGWVASPKTAMPS CCCCCCCCCCCCCCC | 19.81 | 30059200 | |
1010 | Phosphorylation | PSPGWVASPKTAMPS CCCCCCCCCCCCCCC | 19.81 | 28355574 | |
1013 | Phosphorylation | GWVASPKTAMPSPGV CCCCCCCCCCCCCCC | 31.41 | 26657352 | |
1017 | Phosphorylation | SPKTAMPSPGVSQNK CCCCCCCCCCCCCCC | 22.62 | 19664994 | |
1021 | O-linked_Glycosylation | AMPSPGVSQNKQPPL CCCCCCCCCCCCCCC | 33.67 | 30059200 | |
1021 | Phosphorylation | AMPSPGVSQNKQPPL CCCCCCCCCCCCCCC | 33.67 | 30266825 | |
1051 | Phosphorylation | LPPSGPRSSSSAPPA CCCCCCCCCCCCCCC | 37.39 | 28348404 | |
1052 | Phosphorylation | PPSGPRSSSSAPPAN CCCCCCCCCCCCCCC | 29.59 | 28348404 | |
1053 | Phosphorylation | PSGPRSSSSAPPANP CCCCCCCCCCCCCCC | 31.59 | 28348404 | |
1054 | Phosphorylation | SGPRSSSSAPPANPP CCCCCCCCCCCCCCC | 46.90 | 28348404 | |
1072 | Phosphorylation | MNPSLPFTSSPDPTP CCCCCCCCCCCCCCC | 26.76 | 22199227 | |
1073 | O-linked_Glycosylation | NPSLPFTSSPDPTPS CCCCCCCCCCCCCCC | 40.01 | 30059200 | |
1073 | Phosphorylation | NPSLPFTSSPDPTPS CCCCCCCCCCCCCCC | 40.01 | 22199227 | |
1074 | Phosphorylation | PSLPFTSSPDPTPSQ CCCCCCCCCCCCCCC | 30.20 | 22199227 | |
1078 | Phosphorylation | FTSSPDPTPSQNPLS CCCCCCCCCCCCHHH | 42.84 | 22199227 | |
1080 | Phosphorylation | SSPDPTPSQNPLSLM CCCCCCCCCCHHHHH | 45.10 | 22199227 | |
1085 | Phosphorylation | TPSQNPLSLMMTQMS CCCCCHHHHHHHHHH | 18.57 | 22199227 | |
1094 | Phosphorylation | MMTQMSKYAMPSSTP HHHHHHHHCCCCCCC | 10.79 | 29759185 | |
1098 | Phosphorylation | MSKYAMPSSTPLYHN HHHHCCCCCCCCCCC | 33.49 | 29759185 | |
1100 | Phosphorylation | KYAMPSSTPLYHNAI HHCCCCCCCCCCCHH | 22.96 | 24719451 | |
1177 | Phosphorylation | PPPAMLPSPTPLGSN CCCCCCCCCCCCCCC | 37.13 | 26074081 | |
1179 | Phosphorylation | PAMLPSPTPLGSNIP CCCCCCCCCCCCCCC | 35.17 | 26074081 | |
1334 | Acetylation | SRIIPSEKPSSTLQY HHCCCCCCCCCCCCC | 55.31 | 23954790 | |
1344 | Sumoylation | STLQYFPKSENQPPK CCCCCCCCCCCCCCC | 61.58 | - | |
1344 | Sumoylation | STLQYFPKSENQPPK CCCCCCCCCCCCCCC | 61.58 | 28112733 | |
1390 | Phosphorylation | VQRGLNMSMCHPGQM HHHCCCHHHCCCCCH | 19.72 | 27732954 | |
1398 | Phosphorylation | MCHPGQMSLLGRTGV HCCCCCHHHHCCCCC | 16.74 | 27732954 | |
1422 | Phosphorylation | GLHQGVMSPPQGLMT CCCCCCCCCCCCCCH | 30.90 | 23403867 | |
1429 | Phosphorylation | SPPQGLMTQQNFMLM CCCCCCCHHHCEECH | 31.85 | 23403867 | |
1439 | Methylation | NFMLMKQRGVGGEVY CEECHHHHCCCCCCC | 35.92 | - | |
1446 | Phosphorylation | RGVGGEVYSQPPHML HCCCCCCCCCCCCCC | 9.40 | 27642862 | |
1447 | Phosphorylation | GVGGEVYSQPPHMLS CCCCCCCCCCCCCCC | 41.19 | 29523821 | |
1454 | Phosphorylation | SQPPHMLSPQGSLMG CCCCCCCCCCCCCCC | 13.96 | 25159151 | |
1458 | Phosphorylation | HMLSPQGSLMGPPPQ CCCCCCCCCCCCCCC | 15.22 | 25159151 | |
1478 | Phosphorylation | SHPLRQRSVSLDSQM CCCCCCCCCCCCCCC | 14.02 | 25159151 | |
1480 | Phosphorylation | PLRQRSVSLDSQMGY CCCCCCCCCCCCCCC | 27.92 | 28355574 | |
1483 | Phosphorylation | QRSVSLDSQMGYLPA CCCCCCCCCCCCCCC | 27.62 | 23663014 | |
1487 | Phosphorylation | SLDSQMGYLPAPGGM CCCCCCCCCCCCCCC | 12.27 | 18669648 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BCL9L_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BCL9L_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BCL9L_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CTNB1_HUMAN | CTNNB1 | physical | 24360964 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-36; LYS-108 AND LYS-137, ANDMASS SPECTROMETRY. | |
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-36, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88 AND SER-1017, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-25; SER-118;SER-813; SER-999; SER-1004; SER-1010 AND SER-1017, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-750; SER-813; SER-987AND SER-991, AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-25; SER-915;SER-954 AND THR-957, AND MASS SPECTROMETRY. |